Literature DB >> 3312146

Current controversies. Histiocytosis-X.

J McLelland1, J Pritchard, A C Chu.   

Abstract

There are still many areas of controversy concerning Langerhans cell histiocytosis. This article addresses the main controversies and highlights the central factors of this disease, which further investigation should elucidate.

Mesh:

Year:  1987        PMID: 3312146

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 2.  Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?

Authors:  K M Kelly; J Pritchard
Journal:  Br J Cancer Suppl       Date:  1994-09

3.  Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention.

Authors:  Gerald J Harris; Kyung In Woo
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 4.  Langerhans' cell histiocytosis and the nervous system.

Authors:  D J Burn; J D Watson; M Roddie; A C Chu; N J Legg; R S Frackowiak
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.